Drugs / Taro Elixir
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01032499 | May → Jul 2010 | acne, carbuncle | Laboratorios Goulart S.A. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Taro Elixir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01032499 ↗ |
| Route | Oral | “Taken orally one tablespoon (15 mL) of Taro Elixir 3 times daily for breakfast, lunch and dinner.” NCT01032499 ↗ |